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Background
Altered cGMP signaling has been implicated in myocardial depression, morbidity, and mortality associated with sepsis. Previous studies, using inhibitors of soluble guanylate cyclase (sGC), suggested that cGMP generated by sGC contributed to the cardiac dysfunction and mortality associated with sepsis. We used mice deficient in sGCα 1 (sGCα 1 -/-mice) to unequivocally determine the role of sGCα 1 β 1 in the development of cardiac dysfunction and death associated with two models of inflammatory shock: endotoxin-induced and TNF-induced shock.
Results
At baseline, echocardiographic assessment and invasive hemodynamic measurements of left ventricular (LV) dimensions and function did not differ between WT and sGCα 1 -/-mice on the C57BL/6 background (sGCα 1 -/-B6 mice). Fourteen hours after a challenge with endotoxin, cardiac dysfunction was more pronounced in sGCα 1 -/-B6 mice than in WT mice, as assessed using echocardiographic and hemodynamic indices of LV function. Similarly, Ca 2+ handling and cell shortening were impaired to a greater extent in cardiac myocytes isolated from sGCα 1 -/ -B6 mice than in those from WT mice after a challenge with endotoxin. Importantly, morbidity and mortality associated with inflammatory shock induced either by endotoxin or TNF were increased in sGCα 1 -/-B6 mice as compared to WT mice.
Conclusion
Together, these findings suggest that cGMP generated by sGCα 1 β 1 protects against cardiac dysfunction and mortality in murine models of inflammatory shock.
